Total Facility Solutions Opens Hygienic Fabrication Center - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Total Facility Solutions Opens Hygienic Fabrication Center


Total Facility Solutions (TFS), a specialty contractor and services company focused on critical process infrastructure, completed the company’s first certified hygienic fabrication facility dedicated to the US life science market. Located in Burlington, North Carolina, the facility will provide hygienic and high-purity piping fabrication, stainless-steel skid fabrication, and field installations.

Off-site fabrication in a controlled environment has the benefits of cost-effectiveness and minimizing the number of people at the construction site area, which makes the site safer, notes the company. “Moving man-hours from a customer site to a regional fabrication facility helps us streamline our work,” said Joe Cestari, TFS president, in the press release. “Reducing congestion in the facility also reduces risk to safety, quality and schedule, all while meeting the stringent hygienic standards of the life science market.”

Source: Total Facility Solutions

 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here